Aa
Home
Entertainment
Sports
Politics
Fashion
Business
Health
Education
Financial
Home
>
financial

Cantor Fitzgerald maintains Lexeo Therapeutics at Overweight, raises price target to $37 from $23

Ruth Lawson
Published on 2026-11-16 15:56:00
News Site
Cantor Fitzgerald maintains Lexeo Therapeutics at Overweight, raises price target to $37 from $23

Cantor Fitzgerald maintains Lexeo Therapeutics at Overweight, raises price target to $37 from $23

Less than 1 min read

Cantor Fitzgerald maintained Lexeo Therapeutics at Overweight and raised its price target to $37 from $23, a 60.9% increase.

The price target implies an upside of 1189.2% from the Nov 13 close of $2.87.

Explore more price target data and ratings for Lexeo Therapeutics on the Forecasts tab, and track all previous and future analyst recommendations in the dedicated News Flow.

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Read the full article

Get unlimited access to analyst updates and every other article on TradingView.

Recommend

  • Copyright © Pubnews.online
  • Privacy Agreement
  • About us
English